A novel SARS-CoV-2 T cell targeting, peptide-based vaccine candidate designed using the iVAX platform by Riley Nolan | Jun 7, 2022A novel SARS-CoV-2 T cell targeting, peptide-based vaccine candidate designed using the iVAX platform
